379 related articles for article (PubMed ID: 15799210)
1. Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis.
Whitfield JF; Morley P; Willick GE
Treat Endocrinol; 2002; 1(3):175-90. PubMed ID: 15799210
[TBL] [Abstract][Full Text] [Related]
2. Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis.
Whitfield JF; Morley P
Trends Pharmacol Sci; 1995 Nov; 16(11):382-6. PubMed ID: 8578607
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.
Hodsman AB; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; Kendler DL; McClung MR; Miller PD; Olszynski WP; Orwoll E; Yuen CK
Endocr Rev; 2005 Aug; 26(5):688-703. PubMed ID: 15769903
[TBL] [Abstract][Full Text] [Related]
4. Bone growth stimulators. New tools for treating bone loss and mending fractures.
Whitfield JF; Morley P; Willick GE
Vitam Horm; 2002; 65():1-80. PubMed ID: 12481542
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone temporal effects on bone formation and resorption.
Kroll MH
Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
[TBL] [Abstract][Full Text] [Related]
6. Use of teriparatide in osteoporotic fracture patients.
Collinge C; Favela J
Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
[TBL] [Abstract][Full Text] [Related]
7. The parathyroid hormones: bone-forming agents for treatment of osteoporosis.
Whitfield JF; Morley P; Willick GE
Medscape Womens Health; 2000; 5(5):E5. PubMed ID: 11113778
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic targets for osteoporosis: beyond denosumab.
Lim V; Clarke BL
Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of parathyroid hormone.
Cosman F; Lindsay R
Curr Osteoporos Rep; 2004 Mar; 2(1):5-11. PubMed ID: 16036076
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.
Feng Y; Zhou M; Zhang Q; Liu H; Xu Y; Shu L; Zhang J; Miao D; Ren Y
Br J Nutr; 2015 Mar; 113(6):909-22. PubMed ID: 25744000
[TBL] [Abstract][Full Text] [Related]
11. The use of PTH in the treatment of osteoporosis.
Borba VZ; Mañas NC
Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):213-9. PubMed ID: 20485911
[TBL] [Abstract][Full Text] [Related]
12. [Parathyroid hormone for osteroporsis: why and who to treat?].
Ferrari S; Rizzoli R
Rev Med Suisse; 2005 Oct; 1(35):2272-4, 2276-7. PubMed ID: 16268450
[TBL] [Abstract][Full Text] [Related]
13. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
Baumann BD; Wronski TJ
Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone as an anabolic skeletal therapy.
Rubin MR; Bilezikian JP
Drugs; 2005; 65(17):2481-98. PubMed ID: 16296873
[TBL] [Abstract][Full Text] [Related]
15. The cellular and clinical parameters of anabolic therapy for osteoporosis.
Rosen CJ
Crit Rev Eukaryot Gene Expr; 2003; 13(1):25-38. PubMed ID: 12839095
[TBL] [Abstract][Full Text] [Related]
16. Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.
Ebeling PR; Russell RG
Int J Clin Pract; 2003 Oct; 57(8):710-8. PubMed ID: 14627183
[TBL] [Abstract][Full Text] [Related]
17. [Parathyroid hormone and its analogues - molecular mechanisms of action and efficacy of osteoporosis therapy].
Misiorowski W
Endokrynol Pol; 2011; 62 Suppl 2():32-6. PubMed ID: 22125020
[TBL] [Abstract][Full Text] [Related]
18. Osteoanabolic and dual action drugs.
Tabacco G; Bilezikian JP
Br J Clin Pharmacol; 2019 Jun; 85(6):1084-1094. PubMed ID: 30218587
[TBL] [Abstract][Full Text] [Related]
19. The parathyroid hormone, its fragments and analogues--potent bone-builders for treating osteoporosis.
Whitfield J; Morley P; Willick G
Expert Opin Investig Drugs; 2000 Jun; 9(6):1293-315. PubMed ID: 11060744
[TBL] [Abstract][Full Text] [Related]
20. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
